CD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular Carcinoma

Platinum-based therapy is most often used to treat advanced cases of head and neck cancers, but only a small fraction of the patient population responds to cisplatin, with a median survival time of less than a year. Although gene signatures and molecular etiology of head and neck cancers have been p...

Descripción completa

Detalles Bibliográficos
Autores principales: Modur, Vishnu, Joshi, Pooja, Nie, Daotai, Robbins, K. Thomas, Khan, Aziz U., Rao, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898769/
https://www.ncbi.nlm.nih.gov/pubmed/27276062
http://dx.doi.org/10.1371/journal.pone.0156651

Ejemplares similares

Ejemplares similares